FDA Gives Emergency Authorization of Hydroxychloroquine Use

The Food And Drug Administration (FDA) issued an emergency authorization Sunday for hydroxychloroquine, a drug already used to treat malaria and other ailments, which has shown anecdotal efficacy against coronavirus.

The use of the drug — often paired with azithromycin — has not yet been proven in clinical trials to be effective against the disease. However, given reported success in a growing number of small, non-randomized studies; as well as testimonials from doctors and patients about the use of the “off-label” drug regimen, doctors are said to be prescribing the treatment to patients who are severely ill. Anecdotally, many doctors are taking it prophylactically.

The Department of Health and Human Services (HHS) issued a statement on Sunday:

The U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) to BARDA to allow hydroxychloroquine sulfate and chloroquine phosphate products donated to the Strategic National Stockpile (SNS) to be distributed and prescribed by doctors to hospitalized teen and adult patients with COVID-19, as appropriate, when a clinical trial is not available or feasible.

Texas investigating USTA for possible violation of law banning biological males in women’s sports

Federal judge rules law requiring display of Ten Commandments in Texas classrooms unconstitutional

Zelensky under heavy pressure to fire Ukrainian ‘co-president’ Andriy Yermak after corruption scandal

House Dem slammed for ‘sick’ defense of colleague caught texting Epstein during 2019 hearing

DHS launching massive immigration operation in Louisiana, Mississippi: ‘Swamp Sweep’

Anti-Islam protesters, Muslims clash in Dearborn, Michigan, after man attempts to burn Quran

Trump designates Saudi Arabia a major non-NATO ally during crown prince’s White House visit

Illegal immigrant accused of grabbing ICE officer’s taser while shouting ‘Allahu akbar’ during arrest

Trump fetes Saudi crown prince with pseudo-state dinner attended by Cristiano Ronaldo

NYC Mayor-elect Mamdani doubles down on Netanyahu arrest pledge

Thune fields Senate GOP backlash over ‘Arctic Frost’ surveillance provision

Federal prosecutors charge suspect who allegedly vandalized US Attorney Alina Habba’s office

Letitia James and Lisa Cook lawyer pushes back on mortgage fraud allegations

Trump calls for federal AI standards, end to state ‘patchwork’ regulations ‘threatening’ economic growth

Mother and Son Hospitalized After Being Viciously Attacked by a Mob of Elementary School Students

HHS also noted that it had “accepted 30 million doses of hydroxychloroquine sulfate donated by Sandoz, the Novartis generics and biosimilars division, and one million doses of chloroquine phosphate donated by Bayer Pharmaceuticals, for possible use in treating patients hospitalized with COVID-19 or for use in clinical trials.”

Earlier, the French government had approved similar drugs to treat the virus.

Amid concerns that the sudden interest in hydroxychloroquine could cause shortages, HHS noted: “Use of the donated medications is expected to help ease supply pressures for the drug, and the FDA is also working with manufacturers of chloroquine and hydroxychloroquine to increase production to ensure these drugs also remain available for patients dependent on them for treatment of malaria, lupus and rheumatoid arthritis.”